Guardant Health, Inc.: Piper Sandler cuts target price to $190 from $193
GH•Piper Sandler cut its target price for Guardant Health to $190 from $193.
Related News
Akamai announces pricing of convertible senior notes
AKAM•
Leerink Partners cuts Structure Therapeutics target price to $80 from $90
GPCR•
ATS participates in Baird Global Industrial Conference
ATS•
KeyBanc cuts Somnigroup International target price to $100 from $105
SGI•
GRAIL Inc: Piper Sandler raises target price to $130 from $74
GRAL•